ATE525111T1 - 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6- - Google Patents

2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6-

Info

Publication number
ATE525111T1
ATE525111T1 AT04728020T AT04728020T ATE525111T1 AT E525111 T1 ATE525111 T1 AT E525111T1 AT 04728020 T AT04728020 T AT 04728020T AT 04728020 T AT04728020 T AT 04728020T AT E525111 T1 ATE525111 T1 AT E525111T1
Authority
AT
Austria
Prior art keywords
amine
corneal
post
indazolyluquinazoline
indazole
Prior art date
Application number
AT04728020T
Other languages
English (en)
Inventor
Yoshiko Takayama
Yoshikuni Nakamura
Jun Inoue
Mitsuyoshi Azuma
Original Assignee
Senju Pharma Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharma Co filed Critical Senju Pharma Co
Application granted granted Critical
Publication of ATE525111T1 publication Critical patent/ATE525111T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/45—Transferases (2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/454—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. pimozide, domperidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/04—Artificial tears; Irrigation solutions
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y304/00—Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22—Cysteine endopeptidases (3.4.22)
    • C12Y304/22054—Calpain-3 (3.4.22.54), i.e. calpain p94

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Neurology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AT04728020T 2003-04-18 2004-04-16 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6- ATE525111T1 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2003114819 2003-04-18
JP2003273177 2003-07-11
PCT/JP2004/005456 WO2004091662A1 (ja) 2003-04-18 2004-04-16 角膜知覚回復剤

Publications (1)

Publication Number Publication Date
ATE525111T1 true ATE525111T1 (de) 2011-10-15

Family

ID=33302244

Family Applications (1)

Application Number Title Priority Date Filing Date
AT04728020T ATE525111T1 (de) 2003-04-18 2004-04-16 2-chloro-6,7-dimethoxy-n-5 ä5-(1)h- indazolylüquinazolin-4-amin, n-(1-benzyl-4- piperidinyl)-1h-indazol-5-amin dihydrochlorid, 4- ä2-(2,3,4,5,6-

Country Status (9)

Country Link
US (1) US20070093513A1 (de)
EP (1) EP1616577B1 (de)
JP (1) JP4566130B2 (de)
KR (1) KR101076638B1 (de)
CN (1) CN1777445B (de)
AT (1) ATE525111T1 (de)
ES (1) ES2370245T3 (de)
PL (1) PL1616577T3 (de)
WO (1) WO2004091662A1 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20180031066A (ko) 2007-08-29 2018-03-27 센주 세이야꾸 가부시키가이샤 각막 내피 세포 접착 촉진제
US20090325959A1 (en) * 2008-06-26 2009-12-31 Vittitow Jason L Method for treating ophthalmic diseases using rho kinase inhibitor compounds
US10842669B2 (en) * 2008-11-13 2020-11-24 Gholam A. Peyman Ophthalmic drug delivery method
RU2448654C1 (ru) * 2010-12-14 2012-04-27 Государственное образовательное учреждение высшего профессионального образования Смоленская государственная медицинская академия федерального агентства по здравоохранению и социальному развитию Способ диагностики чувствительности роговицы глаза
RU2494735C1 (ru) * 2012-06-21 2013-10-10 Федеральное государственное бюджетное учреждение "Межотраслевой научно-технический комплекс "Микрохирургия глаза" имени академика С.Н. Федорова" Министерства здравоохранения и социального развития Российской Федерации Способ лечения язвы роговицы
WO2016199871A1 (ja) * 2015-06-09 2016-12-15 千寿製薬株式会社 神経麻痺性角膜症の治療薬

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4295259A (en) * 1978-10-13 1981-10-20 Canron Corp. Method of filling spike holes in railway ties
US4678783B1 (en) * 1983-11-04 1995-04-04 Asahi Chemical Ind Substituted isoquinolinesulfonyl compounds
US4661532A (en) * 1985-06-25 1987-04-28 H. B. Fuller Company Coal tar containing foaming urethane composition and a method for repairing defects in structural components
US4738878A (en) * 1987-03-30 1988-04-19 Osmose Wood Preserving, Inc. In situ preservative treatment of railroad tie
NZ334613A (en) 1996-08-12 2002-02-01 Welfide Corp Pharmaceutical agents comprising Rho kinase inhibitor
US5952072A (en) * 1997-06-09 1999-09-14 Willamette Valley Company Method for restoring used railroad ties and the restored railroad ties formed thereby
US6455605B1 (en) * 1997-09-10 2002-09-24 H. B. Fuller Licensing & Financing Inc. Foamable composition exhibiting instant thixotropic gelling
US20080233098A1 (en) * 1997-10-31 2008-09-25 Mckerracher Lisa RHO Family Antagonists and Their Use to Block Inhibition of Neurite Outgrowth
DE69931051D1 (de) * 1998-05-25 2006-06-01 Santen Pharmaceutical Co Ltd Neue vinylbenzolderivate
JP3616867B2 (ja) * 1998-05-25 2005-02-02 参天製薬株式会社 新規ビニルベンゼン誘導体
US7169783B2 (en) * 1998-11-02 2007-01-30 Universite De Montreal (+)-Trans-4-(1-aminoethyl)-1-(4-pyridycarbamoyl)-cyclohexane and method for promoting neural growth in the central nervous system and in a patient at a site of neuronal lesion
KR100818061B1 (ko) * 2000-03-16 2008-04-01 미쯔비시 웰 파마 가부시키가이샤 아미드 화합물 및 그의 용도
TWI336328B (en) * 2001-03-23 2011-01-21 Bayer Healthcare Llc Rho-kinase inhibitors
CA2707827A1 (en) * 2001-04-11 2002-10-24 Senju Pharmaceutical Co., Ltd. Visual function disorder improving agents containing rho kinase inhibitors
US7199147B2 (en) * 2001-06-12 2007-04-03 Dainippon Sumitomo Pharma Co., Ltd. Rho kinase inhibitors
EP1420791A4 (de) * 2001-08-29 2004-09-15 Alcon Inc Verwendung von verbindungen zur behandlung von erkrankungen infolge von verletzungen des hornhautnervs nach lasik- und anderen augenoperationen oder trauma
JP2003073357A (ja) * 2001-09-03 2003-03-12 Mitsubishi Pharma Corp アミド化合物を含有するＲｈｏキナーゼ阻害剤
US6821631B2 (en) * 2001-10-29 2004-11-23 Wood Treatment Products, Inc. Method and composition for treating substrates
US7195823B2 (en) * 2002-06-20 2007-03-27 Mississippi State University Delivery system for supplemental wood preservative and/or metal corrosion inhibition treatment
US7138437B2 (en) * 2003-03-04 2006-11-21 H. B. Fuller Licensing & Financing Inc. Polyurethane composition containing a property-enhancing agent
WO2005118582A1 (ja) * 2004-06-03 2005-12-15 Senju Pharmaceutical Co., Ltd. アミド化合物を含有する角膜知覚回復剤
US20070042161A1 (en) * 2005-08-16 2007-02-22 Gibbs Group Holdings, Inc. Decay resistant wooden railroad crosstie and method for making same
US7632557B2 (en) * 2006-05-17 2009-12-15 Williamette Valley Company Method for restoring used railroad ties and the restored railroad ties formed thereby

Also Published As

Publication number Publication date
PL1616577T3 (pl) 2012-02-29
WO2004091662A1 (ja) 2004-10-28
EP1616577B1 (de) 2011-09-21
EP1616577A4 (de) 2010-03-10
EP1616577A1 (de) 2006-01-18
JPWO2004091662A1 (ja) 2006-07-06
KR101076638B1 (ko) 2011-10-27
CN1777445A (zh) 2006-05-24
KR20050111645A (ko) 2005-11-25
CN1777445B (zh) 2010-04-14
US20070093513A1 (en) 2007-04-26
JP4566130B2 (ja) 2010-10-20
ES2370245T3 (es) 2011-12-13

Similar Documents

Publication Publication Date Title
SE0201976D0 (sv) Novel compounds
SE0201980D0 (sv) Novel compounds
EE05290B1 (et) N-(3,3-dimetlindoliin-6-l){2-[(4-pridlmetl)amino]-(3-pridl)}karboksami id ja selle farmatseutilised kompositsioonid
ATE534391T1 (de) 3,11b-cis-dihydrotetrabenazin zur behandlung von psychosen
DK1680507T3 (da) Bakterieekspression af proteaseinhibitorer og varianter deraf
EP4217352A4 (de) Substituierte n-(2-(2,6-dioxopiperidin-3-yl)-1,3-dioxoisoindolin-5-yl)arylsulfonamidanaloga als modulatoren des cereblonproteins
ATE481093T1 (de) Vervendung von dexrazoxane in der prävention und behandlung der alzeheimer-krankheit
IS7215A (is) Aðferðir til að meðhöndla nýæðarsjúkdóma í augum
GB0117326D0 (en) Napthoquinone-type inhibitors of protein aggregation
ATE550338T1 (de) Spiropiperidininhibitoren von beta-secretase zur behandlung von alzheimer-krankheit
NO2010020I1 (no) 5-{{4-[(2,3-dimetyl-2H-indazot-6-yl)(metyl)amino]pyrimidin-2-yl}amino)-2-metylbenzensulfonamid Pazopanib.
DE60323155D1 (de) Von transthyretin und zur hemmung von transthyretin-fehlfaltung
ATE344253T1 (de) Thiazolderivate zur behandlung von ppar-lierte krankheiten
EP1732484A4 (de) Ophthalmisches implantat zur behandlung von glaukom
TW200736255A (en) 5-(Substituted)-pyrazolopiperidines
DK1532124T3 (da) Anvendelse af nitriderivater som medikament
IL158385A0 (en) Modified cyclosporin which can be used as a pro-drug and use thereof
EP1689766A4 (de) Expression von proteaseinhibitoren und varianten davon in filamentösen pilzen
NO20044250L (no) Heterocykliske amid-derivativer for behandling av diabetes og andre sykdommer
CY1110881T1 (el) Παραγωγα κιναζολινης χρησιμα στη θεραπεια περιφερικης αρτηριακης νοσου και ως αναστολεις της φωσφοδιεστερασης
DE60333205D1 (de) Histaminika zur behandlung von allergischer rhinitis
EA200300392A1 (ru) Производные пиперазина с мостиковой связью
DOP2002000451A (es) Nuevas ciclohexilsulfonas (agentes terapéuticos)
EP1616577A4 (de) Mittel zur wiederherstellung der hornhautwahrnehmung
SE0203712D0 (sv) Novel compounds

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties